Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

Share

Novo Nordisk Pharma Operations A/S

Closing information (x1000 EUR)

Closing information 2023/12 2022/12 2021/12
Turnover 14,532 More Arrow 28,433 Less Arrow 13,263
Earnings before taxes 908 Less Arrow 643 Less Arrow 591
Total assets 10,449 More Arrow 18,255 Less Arrow 9,529
Current assets 9,367 Less Arrow 7,487 More Arrow 8,047
Current liabilities 4,751 Less Arrow 4,701 More Arrow 5,714
Equity capital 3,881 More Arrow 9,643 Less Arrow 2,762
- share capital 67 Equal arrow 67 Equal arrow 67
Employees (average) 0 Equal arrow 0 Equal arrow 0

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 37.1% More Arrow 52.8% Less Arrow 29.0%
Turnover per employee
Profit as a percentage of turnover 6.2% Less Arrow 2.3% More Arrow 4.5%
Return on assets (ROA)
Current ratio 197.2% Less Arrow 159.3% Less Arrow 140.8%
Return on equity (ROE) 23.4% Less Arrow 6.7% More Arrow 21.4%
Change turnover -13,839 More Arrow 15,170 Less Arrow 2,613
Change turnover % -49% More Arrow 114% Less Arrow 25%
Chg. No. of employees 0 Equal arrow 0 Equal arrow 0
Chg. No. of employees %

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.